Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 0800)

Barcelona 08035

0 studies enrolling now · 1 studies all time

What they study most

Renal Cell Carcinoma

Studies at this site

• A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004). — Running, not enrolling